FDA Adds Rare Vision-Loss Warning to Ozempic and Other GLP-1 Drugs
The U.S. Food and Drug Administration (FDA) is requiring manufacturers of popular diabetes and weight-loss medications, including Ozempic, Wegovy and Mounjaro, to add warnings about a rare eye condition that can cause sudden, permanent vision loss. The decision, announced on Nov. 9, 2026, follows an agency review that found a potential increased risk of nonarteritic […]
We haven't written up this one. Colombia One has the full story — the link below goes straight to it.
